These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3895629)

  • 21. Effect of splenectomy on allograft survival and leukocyte migration in rat cardiac transplantation.
    Kuromoto N; Okajima K; Takeda Y; Iga C; Nishi T; Hardy MA
    Bull Osaka Med Sch; 1987 Jul; 33(1):20-6. PubMed ID: 3334131
    [No Abstract]   [Full Text] [Related]  

  • 22. Azathioprine does not potentiate the immunosuppressive effect of 15-deoxyspergualin in rat heart allografting.
    Gannedahl G; Wanders A; Wadström J; Olausson M; Ekberg H; Tufveson G
    Transplant Proc; 1994 Dec; 26(6):3108-10. PubMed ID: 7998085
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of cardiac allograft prolongation by cyclosporin-A.
    Hutchinson IF; Shadur CA; Duarte A; Baldwin WM; Strom TB; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):412-3. PubMed ID: 6455797
    [No Abstract]   [Full Text] [Related]  

  • 24. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pre-treatment of some calcium channel blockers on catalepsy and stereotypic behaviour in rats.
    Khanzode SD; Mahakalkar SM; Belorkar NR; Kharkar VT; Manekar MS
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):159-62. PubMed ID: 9062812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of experimental cardiac allograft survival with thromboxane-related drugs.
    Foegh ML; Khirabadi B; Ramwell PW
    Transplantation; 1985 Aug; 40(2):124-5. PubMed ID: 3161224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival.
    Slakey D; Roza A; Pieper G; Johnson C; Adams M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):610-1. PubMed ID: 8438434
    [No Abstract]   [Full Text] [Related]  

  • 28. Failure of azathioprine and steroids to augment one-day-pretransplant donor-specific transfusion-enhanced allograft survival.
    Madden RL; Brunson ME; Alexander JW; Davies CB
    Transplantation; 1993 Jun; 55(6):1436-8. PubMed ID: 8516833
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of nicardipine, nifedipine, verapamil, and diltiazem on urine volume, sodium and potassium excretion and plasma aldosterone levels in the rat.
    Rosenkranz RP; McClelland DL; Roszkowski AP
    Proc West Pharmacol Soc; 1984; 27():67-72. PubMed ID: 6494200
    [No Abstract]   [Full Text] [Related]  

  • 30. Superiority of continuous infusion of prednisolone over daily injections in the prolongation of heart allograft survival in rats.
    Provoost AP; de Keijzer MH; Kort WJ; Wolff ED
    Transplantation; 1982 Oct; 34(4):221-2. PubMed ID: 6755832
    [No Abstract]   [Full Text] [Related]  

  • 31. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune tolerance induced by combined heart-thymus transplantation for heart allograft in rats].
    Xiong HB; Huang ZF; Ye QF; Xia SS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):47-53. PubMed ID: 17344586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolongation of rat cardiac allograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC; Lei HY; Jin YT; Lee PH; Lee CJ
    Transplant Proc; 1994 Aug; 26(4):2323-6. PubMed ID: 8066761
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relation of Ca2+ efflux from the heart to the concentration of Ca-channel blockers].
    Khmel'-Dunaĭ GN; Narushiavichus EV
    Biull Eksp Biol Med; 1985 Nov; 100(11):559-61. PubMed ID: 4063502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of R- and S-verapamil and nifedipine on rat vascular and intestinal smooth muscle.
    Cleary L; Vandeputte C; Kelly JG; Docherty JR
    Auton Autacoid Pharmacol; 2004 Jul; 24(3):63-7. PubMed ID: 15541013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin.
    Shapira OM; Rene H; Lider O; Pfeffermann RA; Shemin RJ; Cohen IR
    J Surg Res; 1999 Jul; 85(1):83-7. PubMed ID: 10383842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the mechanism of the anti-hypertensive effect of Ca++-blockers.
    Marmo E
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):59-64. PubMed ID: 3952371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.